Extramacular Retinal Hole Following Intravitreal Dexamethasone Implant: Case Report

The intravitreal dexamethasone implant Ozurdex is indicated for the treatment of macular edema due to diabetes and branch retinal vein occlusion. While the most common ocular side effects are elevated intraocular pressure and cataract formation, rare complications related to the injection have been...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Turk oftalmoloji gazetesi 2019-06, Vol.49 (3), p.175-177
Hauptverfasser:	Ekinci, Cansu, Kayıran, Alp, Özdemir, Hakan
Format:	Artikel
Sprache:	eng
Schlagworte:	Case Report Cataracts Central nervous system depressants Deflation (Economics) Dexamethasone Dexamethasone - administration & dosage Dexamethasone - adverse effects Drug Implants - adverse effects Edema Endophthalmitis Fluorescein Angiography - methods Follow-Up Studies Fundus Oculi Glucocorticoids Glucocorticoids - administration & dosage Glucocorticoids - adverse effects Hemorrhage Humans Intravitreal dexamethasone implant Intravitreal Injections - adverse effects Macula Lutea - pathology Macular Edema - diagnosis Macular Edema - drug therapy Macular Edema - etiology Male Middle Aged Ozurdex Pharmaceutical industry Retinal diseases retinal hole Retinal Perforations - chemically induced Retinal Perforations - diagnosis Retinal Vein Occlusion - complications Retinal Vein Occlusion - diagnosis Retinal Vein Occlusion - drug therapy Tıp Tomography, Optical Coherence - methods Visual Acuity
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The intravitreal dexamethasone implant Ozurdex is indicated for the treatment of macular edema due to diabetes and branch retinal vein occlusion. While the most common ocular side effects are elevated intraocular pressure and cataract formation, rare complications related to the injection have been reported. We present a case with extramacular retinal hole after Ozurdex injection.
ISSN:	1300-0659 2149-8695 2149-8709 2147-2661
DOI:	10.4274/tjo.galenos.2019.98975